Alan Chester

författare

• 2008
  • ABO transcript levels in peripheral blood and erythropoietic culture show different allele-related patterns independent of the CBF/NF-Y enhancer motif and multiple novel allele-specific variations in the 5'- and 3'-noncoding regions.
• 2007
  • An extensive polymerase chain reaction-allele-specific polymorphism strategy for clinical ABO blood group genotyping that avoids potential errors caused by null, subgroup, and hybrid alleles
  • Structural basis for red cell phenotypic changes in newly identified, naturally occurring subgroup mutants of the human blood group B glycosyltransferase.
• 2005
  • A clue to the basis of allelic enhancement: occurrence of the A subgroup in the offspring of blood group O parents.
  • New and unusual O alleles at the ABO locus are implicated in unexpected blood group phenotypes.
  • The A phenotype in the ABO blood group system is due to a splice-site mutation in a hybrid between a new O-like allelic lineage and the A allele.
  • Two previously proposed P-1/P-2-differentiating and nine novel polymorphisms at the A4GALT (P-k) locus do not correlate with the presence of the P1 blood group antigen
• 2004
  • A novel blood group B subgroup: serological and genetic studies
• 2001
  • Polymorphism and recombination events at the ABO locus: a major challenge for genomic ABO blood grouping strategies
  • The ABO blood group gene: a locus of considerable genetic diversity
• 1999
  • Allele-related variation in minisatellite repeats involved in the transcription of the blood group ABO gene
• 1998
  • Different genotypes causing indiscernible patterns of A expression on A(el) red blood cells as visualized by scanning immunogold electron microscopy
  • Heterogeneity of the O alleles at the blood group ABO locus in Amerindians
  • Heterogeneity of the blood group Ax allele: genetic recombination of common alleles can result in the Ax phenotype
  • IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN). Nomenclature of glycolipids--recommendations 1997
• 1997
  • Molecular analysis of the O alleles at the blood group ABO locus in populations of different ethnic origin reveals novel crossing-over events and point mutations
• 1996
  • Evidence for a new type of O allele at the ABO locus, due to a combination of the A2 nucleotide deletion and the Ael nucleotide insertion
  • Frequent occurrence of a variant O1 gene at the blood group ABO locus
  • Polymorphisms at the ABO locus in subgroup A individuals
• 1995
  • A rapid and simple ABO genotype screening method using a novel B/O2 versus A/O2 discriminating nucleotide substitution at the ABO locus
  • An Ael allele-specific nucleotide insertion at the blood group ABO locus and its detection using a sequence-specific polymerase chain reaction
• 1993
  • Improved removal of anti-A and anti-B antibodies from plasma using blood-group-active haptens
• 1991
  • Differential effect of hypothermia on the vascular tone and reactivity of the human coronary artery and graft vessels
• 1988
  • Blood group active haptens in urine and faeces
  • Oligosaccharides from faeces of a blood-group B, breast-fed infant
  • Oligosaccharides from feces of preterm infants fed on breast milk
  • Urinary excretion of a glucose-containing tetrasaccharide. A parameter for increased degradation of glycogen
• 1987
  • Lewis blood group antigens in urine sediments from patients with urinary bladder carcinoma
• 1986
  • Comparative immunohistochemical demonstration of difucosylated carbohydrate antigens and CEA in adenomas and carcinomas of the rectum and rectosigmoid
• 1984
  • Blood group specific oligosaccharides from faeces of a blood group A breast-fed infant
  • First-trimester diagnosis on chorionic villi obtained by direct vision technique
  • Immunochemical characterization of a monoclonal anti-Leb blood grouping reagent
  • Mouse monoclonal antibodies with anti-A, anti-B and anti-A,B specificities; some superior to human polyclonal ABO reagents
• 1983
  • Diagnostisk korionbiopsi vid Lasarettet i Lund
  • Free N-acetylneuraminic acid in tissues in Salla disease and the enzymes involved in its metabolism
  • Increased urinary excretion of a glycogen-derived tetrasaccharide in heterozygotes with glycogen storage diseases type II and III
  • The first case of the Sanfilippo type C syndrome in Scandinavia
• 1982
  • Isolation and characterisation of 4-O-beta-D-mannopyranosyl-2-acetamido- 2-deoxy-D-glucose from the urine of a patient with mucolipidosis II and its occurrence in normal and pathological urine
• 1981
  • Lewis phenotype of erythrocytes and Leb-active glycolipid in serum of pregnant women
• 1979
  • A new N-acetyl-beta-D-hexosaminidase disease with late onset of progressive neurological symptoms
  • Increased urinary excretion of free N-acetylneuraminic acid in thirteen patients with Salla disease
  • Urinary excretion of oligosaccharides induced by galactose given orally or intravenously
• 1978
  • Isolation and characterization of oligosaccharides from urine of patients with abnormal glycoconjugate metabolism
  • Isolation and characterization of oligosaccharides from urine of patients with abnormal glycoconjugate metabolism
• 1977
  • A comparison of the alpha-L-fucosidase activities of human liver and serum
  • Biosynthesis of the blood-group-B-specific trisaccharide in a rhesus monkey
• 1976
  • Phenyl beta-D-Galactopyranoside as an Acceptor Substrate for the Blood-Group H Gene-Associated Guanosine Diphosphate L-Fucose:beta-D-Galactosyl alpha-2-L-Fucosyltransferase
  • The common identity of five glycosidases in human liver
• 1975
  • The relationship between different forms of human alpha-mannosidase
• 1974
  • The occurrence of a beta-galactosyltransferase in normal human urine
• 1972
  • α-l-FucosyItransferases in Human Serum from Donors of Different ABO, Secretor and Lewis Blood-Group Phenotypes
• 1969
  • Alpha-L-fucosyltransferases in human submaxillary gland and stomach tissues associated with the H, Lea and Leb blood-group characters and ABH secretor status